Auk, further to your great research.
- The Anagrelide metabolite (3-hydroxy-anagrelide) is likely to be the main contributor to the negative cardiovascular effects of the drug. (TGA PAR ref)
- (Suda update 21 Feb 2019)
No liver metabolism = no metabolite = no cardio vascular impacts
All good really.
Now some good news that affects the share price (positively) would be appreciated Carter.
- Forums
- ASX - By Stock
- Anagrelide
Auk, further to your great research. The Anagrelide metabolite...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALA (ASX) to my watchlist
(20min delay)
|
|||||
Last
14.5¢ |
Change
0.015(11.5%) |
Mkt cap ! $152.3M |
Open | High | Low | Value | Volume |
13.5¢ | 14.5¢ | 13.0¢ | $168.0K | 1.212M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 71428 | 14.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.5¢ | 5994 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 71428 | 0.140 |
5 | 197148 | 0.135 |
10 | 670430 | 0.130 |
16 | 873527 | 0.125 |
22 | 1172427 | 0.120 |
Price($) | Vol. | No. |
---|---|---|
0.145 | 5994 | 1 |
0.150 | 443554 | 10 |
0.155 | 684615 | 4 |
0.160 | 434386 | 4 |
0.165 | 425000 | 3 |
Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
Featured News
ALA (ASX) Chart |